Simplify Asset Management Inc. Boosts Stock Position in Establishment Labs Holdings Inc. $ESTA

Simplify Asset Management Inc. boosted its holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 92.1% during the fourth quarter, Holdings Channel reports. The institutional investor owned 72,894 shares of the company’s stock after buying an additional 34,946 shares during the period. Simplify Asset Management Inc.’s holdings in Establishment Labs were worth $5,313,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Quarry LP acquired a new stake in Establishment Labs in the 3rd quarter worth about $34,000. State of Wyoming acquired a new stake in Establishment Labs in the 3rd quarter worth about $71,000. Osaic Holdings Inc. boosted its stake in Establishment Labs by 900.0% in the 2nd quarter. Osaic Holdings Inc. now owns 2,000 shares of the company’s stock worth $85,000 after buying an additional 1,800 shares during the last quarter. Truist Financial Corp acquired a new stake in Establishment Labs in the 4th quarter worth about $200,000. Finally, PharVision Advisers LLC acquired a new stake in Establishment Labs in the 3rd quarter worth about $203,000. 72.91% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have issued reports on ESTA. Canaccord Genuity Group raised their price target on Establishment Labs from $85.00 to $90.00 and gave the stock a “buy” rating in a research note on Thursday, February 26th. Citigroup reissued a “neutral” rating on shares of Establishment Labs in a research note on Wednesday, May 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of Establishment Labs in a research note on Friday, March 27th. Needham & Company LLC raised their price target on Establishment Labs from $84.00 to $86.00 and gave the stock a “buy” rating in a research note on Tuesday, February 24th. Finally, Stephens raised their price target on Establishment Labs from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 25th. Six research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $87.14.

Insider Buying and Selling at Establishment Labs

In other news, Director Quiros Juan Jose Chacon sold 105,000 shares of Establishment Labs stock in a transaction dated Wednesday, May 6th. The stock was sold at an average price of $75.42, for a total value of $7,919,100.00. Following the transaction, the director directly owned 927,504 shares of the company’s stock, valued at $69,952,351.68. The trade was a 10.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Over the last quarter, insiders sold 330,000 shares of company stock valued at $22,854,538. Insiders own 9.99% of the company’s stock.

Establishment Labs Stock Performance

NASDAQ ESTA opened at $72.19 on Monday. The firm has a market capitalization of $2.12 billion, a P/E ratio of -48.45 and a beta of 1.12. Establishment Labs Holdings Inc. has a 1-year low of $33.35 and a 1-year high of $83.31. The company has a debt-to-equity ratio of 16.82, a current ratio of 2.96 and a quick ratio of 1.91. The business’s 50-day simple moving average is $64.59 and its 200-day simple moving average is $68.08.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings data on Thursday, May 7th. The company reported ($0.45) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.10). The firm had revenue of $59.88 million during the quarter, compared to analyst estimates of $57.40 million. Establishment Labs had a negative net margin of 19.05% and a negative return on equity of 218.77%. The business’s revenue for the quarter was up 44.7% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.70) earnings per share. Equities analysts predict that Establishment Labs Holdings Inc. will post -1.07 EPS for the current year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.